Sign in

CIK 0001830487

  • Large accelerated filer

Pharvaris N.V.

Sign in to watch
Ticker
PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Other
Phone
+31 712036410
Business address
J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, Netherlands
Former names
Pharvaris, B.V.
  1. 4 Planned sale Chief Executive Officer sold 2,292 shares at $34.77 ($79,686)
  2. 4 Shares withheld for taxes President gave up 226 shares (to pay taxes)
  3. 4 Planned sale Chief Executive Officer sold 2,292 shares at $34.97 ($80,154)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 226 shares (to pay taxes)
  5. 4 Planned sale Director sold 37,600 shares at an average $35.41 ($1,331,496)
  6. 4 Planned sale Chief Early Development sold 76,172 shares at an average $35.39 ($2,695,452)
  7. 4 Planned sale Chief Early Development sold 4,600 shares at an average $35.12 ($161,560)
  8. 4 Planned sale Director sold 2,400 shares at $35.10 ($84,250)
  9. 4 Planned sale Chief Medical Officer sold 29,700 shares at an average $34.30 ($1,018,832)
  10. 4 Planned sale Chief Medical Officer sold 300 shares at $34.00 ($10,200)
  11. 4 Planned sale Chief Executive Officer sold 2,291 shares at an average $31.07 ($71,173)
  12. 4 Shares withheld for taxes Chief Medical Officer gave up 117 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Medical Officer gave up 109 shares (to pay taxes)
  14. 4 Open-market sale Principal Accounting Officer sold 2,670 shares at $30.87 ($82,425)
  15. 4 Open-market sale Director sold 9,667 shares at $30.29 ($292,853)
  16. 4 Open-market sale Principal Accounting Officer sold 7,330 shares at an average $30.70 ($225,055)
  17. 4 Open-market sale CFO / CLO sold 10,000 shares at $30.31 ($303,076)
  18. 4 Planned sale Director sold 10,000 shares at $29.32 ($293,166)
  19. 4/A Insider Changes in Ownership
  20. 4 Planned sale Chief Executive Officer sold 2,292 shares at $29.22 ($66,977)

Page 2 of 4 · 71 filings